Eleven Biotherapeutics, a protein-based biotherapeutics developer, has secured $20 million in Series A equity financing, expanding its total Series A funding to $55 million. In the latest Series A round, new investor JAFCO invested $10 million, while existing investors Third Rock Ventures and Flagship Ventures put down the other $10 million.
